Where does Ocera Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ocera Therapeutics, Inc. ranks #14,826 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ocera Therapeutics, Inc. hold?

Ocera Therapeutics, Inc. holds 20 US utility patents granted between 2015 and 2022, spanning 12 technology areas.

What is Ocera Therapeutics, Inc.'s Innovation Score?

Ocera Therapeutics, Inc. has an Innovation Score of 33.7 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ocera Therapeutics, Inc. focus on?

Ocera Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 17 patents, ranking #1,331 of 7,163 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Ocera Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Ocera Therapeutics, Inc.'s recent grant velocity is -57% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ocera Therapeutics, Inc.'s patents?

Ocera Therapeutics, Inc.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ocera Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ocera Therapeutics, Inc.

USPTO PatentsView assignee record - 20 granted patents across 12 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ocera ranks #14,826 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 12 technology areas.

#14,826
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.7/100): 14.6
avg claims per patent: -57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14826 · US Corporation #14,826 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,826/49,997
PHOTO-FINISH Oakland University
CPC-FOCUS A61K · 12 areas
INNOV-THIN 33.7/100
CLAIMS-RICH 14.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oakland University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ocera’s 33.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (31%) Velocity 2.2 pts (7%) Breadth 12.2 pts (36%) Claim depth 8.7 pts (26%)

Qualcomm Incorporated · highest

85
Ocera Therapeutics · this assignee

34
3D Lighting… · lowest

7

What this shows Ocera's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ocera?

Each dot is one of Ocera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ocera’s own 14.6 claims/patent is ABOVE the 11.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ocera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ocera's grants concentrate

Ocera Therapeutics, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 85% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2017. By volume, Ocera sits between Opsys Tech Ltd. and Optovate Limited.

Ocera's three-year grant acceleration

Ocera Therapeutics, Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Opsys Tech

20
Optimal Plus

20
Overland Storage

20
Oakland University

20
Olin

20
Omega (Omega )(Om…

20
Oneida Air Systems

20
Optovate

20
Ocera Therapeutics ◀

20

What this shows Ocera holds 20 patents at rank #14,828, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ocera

By rank, the assignees closest to #14,828 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Ocera's primary technology class.

Ocera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ocera Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	25.0%
2016	4	20.0%
2017	1	5.0%
2018	2	10.0%
2019	2	10.0%
2020	2	10.0%
2021	2	10.0%
2022	2	10.0%

Which technologies does Ocera Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 17

C07C - Acyclic OR Carbocyclic Compounds 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C07D - Heterocyclic Compounds 7

C07K - Peptides 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ocera Therapeutics, Inc.'s patent record in context - here's where to go next.

Ocera Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 85% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #14,826 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ocera Therapeutics, Inc. against Opsys Tech Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.